|

MDX2001 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • ModeX Therapeutics, An OPKO Health Company1

Indications

  • Liver Disease1
  • GastroEsophageal Cancer1
  • Biliary Tract Cancer1
  • Renal Cancer1
  • Rectal Cancer1

Denver, Colorado1 trial

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Sarah Cannon Research Institute

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.